97401213 - HYLORIS

Information

  • Trademark
  • 97401213
  • Serial Number
    97401213
  • Filing Date
    May 09, 2022
    2 years ago
  • Transaction Date
    December 03, 2024
    a month ago
  • Status Date
    December 03, 2024
    a month ago
  • Published for Opposition Date
    December 03, 2024
    a month ago
  • Location Date
    October 21, 2024
    2 months ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CORDANI, CAITLIN
  • Attorney Docket Number
    HBRAN-T350-U
    Attorney Name
    Clifford D Hyra
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4
Mark Identification
HYLORIS
Case File Statements
  • GS0401: Custom manufacture of cardiovascular pharmaceuticals and medicines for treatment of cardiovascular diseases by pharmaceutical compounders; providing technical information in the field of pharmaceutical manufacturing of cardiovascular pharmaceuticals; biomanufacturing for others, namely, manufacturing of cardiovascular pharmaceuticals using biological organisms in the manufacturing process
  • GS0051: Cardiovascular pharmaceuticals; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of cardiovascular and cardiopulmonary diseases and disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; none of the aforementioned for the treatment of non-cardiological inflammatory disorders
  • GS0421: Pharmaceutical research and development services in the field of cardiovascular and cardiopulmonary disease and disorders; Development of cardiovascular pharmaceutical preparations and medicines for the treatment of cardiovascular diseases; cardiovascular pharmaceutical products development; Laboratory research services in the field of pharmaceuticals and new products, namely, cardiovascular pharmaceutical and biotechnological products in the nature of cardiovascular pharmaceuticals; conducting early evaluations in the field of new cardiovascular pharmaceuticals; testing, inspection and research of cardiovascular pharmaceuticals; research and development in the biotechnology fields in relation to cardiovascular and cardiopulmonary diseases and disorders; technical consulting services in the fields of pharmaceutical research and development, biotechnology; technical consulting services in the field of scientific laboratory services, namely, laboratory testing, diagnostics; all the aforementioned in relation to cardio vascular and cardiopulmonary diseases and disorders
Case File Event Statements
  • 5/12/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/13/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/31/2022 - 2 years ago
    3 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/31/2022 - 2 years ago
    4 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/31/2022 - 2 years ago
    5 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/31/2022 - 2 years ago
    6 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 10/31/2022 - 2 years ago
    7 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/31/2022 - 2 years ago
    8 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/18/2022 - 2 years ago
    9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/18/2022 - 2 years ago
    10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/18/2022 - 2 years ago
    11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 2/27/2023 - a year ago
    12 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/15/2023 - a year ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/15/2023 - a year ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/15/2023 - a year ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/15/2023 - a year ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/17/2023 - a year ago
    17 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/17/2023 - a year ago
    18 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 3/17/2023 - a year ago
    19 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 9/18/2023 - a year ago
    20 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 9/18/2023 - a year ago
    21 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 9/18/2023 - a year ago
    22 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 11/29/2023 - a year ago
    23 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 4/18/2024 - 8 months ago
    24 - ASSIGNED TO LIE Type: ALIE
  • 4/18/2024 - 8 months ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/18/2024 - 8 months ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/9/2024 - 8 months ago
    27 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/9/2024 - 8 months ago
    28 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/9/2024 - 8 months ago
    29 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 7/16/2024 - 5 months ago
    32 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/16/2024 - 5 months ago
    31 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/9/2024 - 4 months ago
    34 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/9/2024 - 4 months ago
    33 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/9/2024 - 4 months ago
    35 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/15/2024 - 5 months ago
    30 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 9/18/2024 - 3 months ago
    38 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/18/2024 - 3 months ago
    37 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/18/2024 - 3 months ago
    36 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/15/2024 - 2 months ago
    39 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/27/2024 - a month ago
    40 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/3/2024 - a month ago
    41 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/3/2024 - a month ago
    42 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB